Cerulean Pharma
Drug Stores & Pharmacies · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
840 Memorial Dr, Cambridge, Massachusett...Phone Number
(774) 301-8007Website
www.ceruleanrx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cerulean Pharma
Cerulean Pharma, founded in 2006, is a pharmaceutical company that develops innovative cancer treatments using their Dynamic Tumor Targeting Platform. The company creates nanoparticle-drug conjugates designed to target tumor cells while reducing toxicity to normal cells. Cerulean Pharma focuses on enabling therapeutic combinations in oncology, with multiple clinical candidates undergoing trials. The company operates across multiple locations and specializes in developing targeted drug delivery systems for cancer therapy.Explore more
Cerulean Pharma Org Chart
ES
Office Manager
SH
Manager, Business Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cerulean Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Cerulean Pharma recently announced quarterly report
Check if Cerulean Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cerulean Pharma launches new products
Funding: Get notified immidiatlly once Cerulean Pharma has new funding data
Cerulean Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Cerulean Pharma is spiking on competitors!
Click to see if Cerulean Pharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Cerulean Pharma
Recommended Actions
Find VP level buyers at Cerulean Pharma
Find 3 more new buyers
Compare Similar Companies to Cerulean Pharma
Compare insights from companies similar to Cerulean Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cerulean Pharma
<$5M
11-50
Private
-
2006
VM
Valerie McLaughlinOffice Manager and Recruitment Coordinator
Company Profile Activity
Activity Insights
Cerulean Pharma is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Cerulean Pharma is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Cerulean Pharma.
Cerulean Pharma Tech Stack
A closer look at the technologies used by Cerulean Pharma
See more technologies
Cerulean Pharma News & Media
Daré Bioscience Announces Alignment with the FDA on Phase 2b Study Design and Novel Primary Endpoint PRO Instruments to Support the Continued Clinical Development of Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
Sildenafil Cream, 3.6% has the Potential to Be the First FDA-Approved Product for FSAD Sildenafil Cream, 3.6% has the Potential to Be the First FDA-Approved Product for FSADDaré Bioscience and Strategic Science & Technologies Announce Presentation of Positive Findings from Thermography Clinical Study of Sildenafil Cream, 3.6 % in Healthy Women at the Sexual Medicine Society of North America Conference
Sildenafil Cream, 3.6% produced statistically significant and clinically meaningful responses compared to placebo cream, further validating the potential for Sildenafil Cream, 3.6% to be an on-demand treatment for FSAD. Sildenafil Cream, 3.6% produced statistically significant and clinically meaningful responses compared to placebo cream, further validating the potential for Sildenafil Cream, 3.6% to be an on-demand treatment for FSAD.Companies Like Daré Bioscience (NASDAQ:DARE) Can Be Considered Quite Risky
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...Daré Bioscience Announces Completion of its Content Validity Study to Support the Continued Clinical Development of Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
Sildenafil Cream, 3.6% has the Potential to Be the First FDA-Approved Product for FSAD Sildenafil Cream, 3.6% has the Potential to Be the First FDA-Approved Product for FSAD
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cerulean Pharma
Sign Up For FreeTo access detailed company insights
Cerulean Pharma, founded in 2006, is a pharmaceutical company that develops innovative cancer treatments using their Dynamic Tumor Targeting Platform. The company creates nanoparticle-drug conjugates designed to target tumor cells while reducing toxicity to normal cells. Cerulean Pharma focuses on enabling therapeutic combinations in oncology, with... Read More
